Astrocytic connexin 43-hemichannels aggravate seizures by modulating blood-brain barrier permeability in temporal lobe epilepsy mice

Abstract

The involvement of astrocytic connexin 43 (Cx43) in epileptogenesis has been extensively studied through various approaches, yet the underlying mechanism remains enigmatic. In this study, we explored whether astrocytic Cx43 forms hemichannels (HCs) that contribute to seizure progression in temporal lobe epilepsy (TLE) in mice. We focused on how these HCs influence the permeability of the blood-brain barrier (BBB), a crucial factor in the pathophysiology of epilepsy. Immunofluorescence staining and western blot analysis were employed to assess Cx43 expression in kainic acid-induced TLE mice, while BBB permeability was evaluated in TLE mice and those treated with TAT-Gap19 (an astrocytic Cx43 HC inhibitor) using Evans Blue permeation, serum S100β protein quantification, ZO-1 expression, and albumin extravasation into brain parenchyma via western blotting. Furthermore, seizure burden was monitored continuously using telemetric electroencephalography (EEG) and video monitoring in epileptic and TAT-Gap19-treated mice. Results demonstrated a significant increase in Cx43 content in hippocampal tissue in the TLE group, with a pronounced expression around blood vessels. TAT-GAP19 treatment alleviated EEG seizures and BBB permeability in TLE mice. These findings suggest that astrocytic Cx43 HCs in the hippocampus play a crucial role in epileptogenesis and seizure progression by regulating BBB permeability. Targeting Cx43-formed HCs distributed around the neurovascular unit may offer a novel therapeutic approach for epilepsy.

Keywords

astrocytes / blood-brain barrier / Cx43 / epilepsy / hippocampus

References

[1] FisherRS, Acevedo C, ArzimanoglouA, et al. ILAE official report: a practical clinical definition of epilepsy. Epilepsia. 2014;55(4):475-482.

[2] KwanP, BrodieMJ. Early identification of refractory epilepsy. N Engl J Med. 2000;342(5):314-319.

[3] VezzaniA, Ravizza T, BednerP, AronicaE, Steinhäuser C, BoisonD. Astrocytes in the initiation and progression of epilepsy. Nat Rev Neurol. 2022;18(12):707-722.

[4] SolanJL, LampePD. Src regulation of Cx43 phosphorylation and gap junction turnover. Biomolecules. 2020;10(12):1596.

[5] DeshpandeT, LiT-S, HerdeMK, et al. Subcellular reorganization and altered phosphorylation of the astrocytic gap junction protein connexin43 in human and experimental temporal lobe epilepsy. Glia. 2017;65(11):1809-1820.

[6] JohnsonAM, RoachJP, HuA-N, et al. Connexin 43 gap junctions contribute to brain endothelial barrier hyperpermeability in familial cerebral cavernous malformations type III by modulating tight junction structure. FASEB J. 2018;32(5):2615-2629.

[7] RusinaE, Bernard C, WilliamsonA. The kainic acid models of temporal lobe epilepsy. eNeuro. 2021;8(2):ENEURO.0337-ENEURO.0320.2021.

[8] WangZ-F, Higashikawa K, YasuiH, et al. FTY720 protects against ischemia-reperfusion injury by preventing the redistribution of tight junction proteins and decreases inflammation in the subacute phase in an experimental stroke model. Transl Stroke Res. 2020;11(5):1103-1116.

[9] OrellanaJA, FrogerN, EzanP, et al. ATP and glutamate released via astroglial connexin 43 hemichannels mediate neuronal death through activation of pannexin 1 hemichannels. J Neurochem. 2011;118(5):826-840.

[10] ZhangQJ, ZhengTG, ChengT, Jia JY, LiangJH. Establishment of sub-scalp electroencephalogram electrode embedding method in rats and mice (In Chinese). Chin J Pharm Toxicol. 2021;35(5):366-373.

[11] RacineRJ. Modification of seizure activity by electrical stimulation: II. Motor seizure. Electroencephalogr Clin Neurophysiol. 1972;32(3):281-294.

[12] ChenK-N, GuanQ-W, YinX-X, Wang Z-J, ZhouH-H, MaoX-Y. Ferrostatin-1 obviates seizures and associated cognitive deficits in ferric chloride-induced posttraumatic epilepsy via suppressing ferroptosis. Free Radic Biol Med. 2022;179:109-118.

[13] FuruseM, Tsukita S. Claudins in occluding junctions of humans and flies. Trends Cell Biol. 2006;16(4):181-188.

[14] WangN, de Vuyst E, PonsaertsR, et al. Selective inhibition of Cx43 hemichannels by Gap19 and its impact on myocardial ischemia/reperfusion injury. Basic Res Cardiol. 2013;108(1):309.

[15] ZabrodskayaY, Paramonova N, LitovchenkoA, et al. Neuroinflammatory dysfunction of the blood-brain barrier and basement membrane dysplasia play a role in the development of drug-resistant epilepsy. Int J Mol Sci. 2023;24(16):12689.

[16] CharvériatM, Naus CC, LeybaertL, SáezJC, GiaumeC. Connexin-dependent neuroglial networking as a new therapeutic target. Front Cell Neurosci. 2017;11:174.

[17] OrellanaJA, Retamal MA, Moraga-AmaroR, StehbergJ. Role of astroglial hemichannels and pannexons in memory and neurodegenerative diseases. Front Integr Neurosci. 2016;10:26.

[18] DeshpandeT, LiT-S, HenningL, et al. Constitutive deletion of astrocytic connexins aggravates kainate-induced epilepsy. Glia. 2020;68(10):2136-2147.

[19] BednerP, DupperA, HüttmannK, et al. Astrocyte uncoupling as a cause of human temporal lobe epilepsy. Brain. 2015;138(Pt 5):1208-1222.

[20] WalraveL, PierreA, AlbertiniG, et al. Inhibition of astroglial connexin43 hemichannels with TAT-Gap19 exerts anticonvulsant effects in rodents. Glia. 2018;66(8):1788-1804.

[21] GuoA-N, ZhangH-Q, LiH-H, et al. Inhibition of connexin hemichannels alleviates neuroinflammation and hyperexcitability in temporal lobe epilepsy. Proc Natl Acad Sci USA. 2022;119(45):e2213162119.

[22] ObermeierB, Daneman R, RansohoffRM. Development, maintenance and disruption of the blood-brain barrier. Nat Med. 2013;19(12):1584-1596.

[23] AbbottNJ, Patabendige AAK, DolmanDEM, YusofSR, BegleyDJ. Structure and function of the blood-brain barrier. Neurobiol Dis. 2010;37(1):13-25.

[24] BallabhP, BraunA, NedergaardM. The blood-brain barrier: an overview: structure, regulation, and clinical implications. Neurobiol Dis. 2004;16(1):1-13.

[25] LöscherW, Friedman A. Structural, molecular, and functional alterations of the blood-brain barrier during epileptogenesis and epilepsy: a cause, consequence, or both? Int J Mol Sci. 2020;21(2):591.

[26] MichettiF, Clementi ME, Di LiddoR, et al. The S100B protein: a multifaceted pathogenic factor more than a biomarker. Int J Mol Sci. 2023;24(11):9605.

[27] KawataK, LiuCY, MerkelSF, Ramirez SH, TierneyRT, LangfordD. Blood biomarkers for brain injury: what are we measuring? Neurosci Biobehav Rev. 2016;68:460-473.

[28] van VlietEA, Aronica E, GorterJA. Blood-brain barrier dysfunction, seizures and epilepsy. Semin Cell Dev Biol. 2015;38:26-34.

[29] VazanaU, Veksler R, PellGS, et al. Glutamate-mediated blood-brain barrier opening: implications for neuroprotection and drug delivery. J Neurosci. 2016;36(29):7727-7739.

[30] van LanenRH, Melchers S, HooglandG, et al. Microvascular changes associated with epilepsy: a narrative review. J Cerebr Blood Flow Metabol. 2021;41(10):2492-2509.

[31] CheungG, Bataveljic D, VisserJ, et al. Physiological synaptic activity and recognition memory require astroglial glutamine. Nat Commun. 2022;13(1):753.

[32] CarmignotoG, HaydonPG. Astrocyte calcium signaling and epilepsy. Glia. 2012;60(8):1227-1233.

[33] PurnellBS, AlvesM, BoisonD. Astrocyte-neuron circuits in epilepsy. Neurobiol Dis. 2023;179:106058.

[34] ChandrasekharA, BeraAK. Hemichannels: permeants and their effect on development, physiology and death. Cell Biochem Funct. 2012;30(2):89-100.

[35] LeiL, WangY-T, HuD, GaiC, ZhangY. Astroglial connexin 43-mediated gap junctions and hemichannels: potential antidepressant mechanisms and the link to neuroinflammation. Cell Mol Neurobiol. 2023;43(8):4023-4040.

[36] DelvaeyeT, Vandenabeele P, BultynckG, LeybaertL, KryskoDV. Therapeutic targeting of connexin channels: new views and challenges. Trends Mol Med. 2018;24(12):1036-1053.

[37] XhimaK, Weber-Adrian D, SilburtJ. Glutamate induces blood-brain barrier permeability through activation of N-methyl-D-aspartate receptors. J Neurosci. 2016;36(49):12296-12298.

[38] WangY-M, ZhuY-B, WangJ-M, et al. Purinergic signaling: a gatekeeper of blood-brain barrier permeation. Front Pharmacol. 2023;14:1112758.

[39] TachikawaM, Murakami K, AkaogiR, AkanumaSI, Terasaki T, HosoyaKI. Polarized hemichannel opening of pannexin 1/connexin 43 contributes to dysregulation of transport function in blood-brain barrier endothelial cells. Neurochem Int. 2020;132:104600.

[40] ZhanR, MengX, TianD-P, et al. NAD⁺ rescues aging-induced blood-brain barrier damage via the CX43-PARP1 axis. Neuron. 2023;111(22):3634-3649.e7.

RIGHTS & PERMISSIONS

2024 The Author(s). Pediatric Discovery published by John Wiley & Sons Australia, Ltd on behalf of Children’s Hospital of Chongqing Medical University.